Price
CHART BY
Frequently asked questions
What is Magforce's market capitalization?
The market capitalization of Magforce is 89.80K. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Magforce?
Magforce's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.356. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Magforce's stock?
Currently, 1 analysts cover Magforce's stock, with a consensus target price of 9.15. Analyst ratings provide insights into the stock's expected performance.
What is Magforce's revenue over the trailing twelve months?
Over the trailing twelve months, Magforce reported a revenue of 351.98K.
What is the EBITDA for Magforce?
Magforce's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -5.93M. EBITDA measures the company's overall financial performance.
How many employees does Magforce have, and what sector and industry does it belong to?
Magforce employs approximately 32 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Magforce's shares?
The free float of Magforce is 22.71M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- 89.80K
- EPS (TTM)
- -$0.356
- Free Float
- 22.71M
- Revenue (TTM)
- 351.98K
- EBITDA (TTM)
- -5.93M
Pricing
- 1D span
- $0.003491$0.003492
- 52W span
- $0.001152$0.0214
Analyst Ratings
The price target is 9.15 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
MagForce AG engages in the development and distribution of a nanotechnology based cancer therapy. It offers Nanotherm therapy, which includes a liquid containing iron oxide nanoparticles that interact with an alternating magnetic field to destroy cancer cells, as well as an application, in which the progress of the therapy can be planned and documented. The company was founded in 1997 and is headquartered in Berlin, Germany.
- Employees
- 32
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- DE000A0HGQF5
- Primary Ticker
- MF6
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet